Louisiana State Employees Retirement System Buys New Position in Solventum Corporation $SOLV

Louisiana State Employees Retirement System bought a new stake in shares of Solventum Corporation (NYSE:SOLV) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 7,500 shares of the company’s stock, valued at approximately $490,000.

Several other institutional investors have also added to or reduced their stakes in SOLV. Hilltop National Bank grew its position in shares of Solventum by 71.3% during the 4th quarter. Hilltop National Bank now owns 310 shares of the company’s stock valued at $25,000 after acquiring an additional 129 shares during the period. CrossGen Wealth LLC bought a new position in Solventum in the 4th quarter worth $25,000. Measured Wealth Private Client Group LLC purchased a new position in Solventum during the third quarter valued at $25,000. JNBA Financial Advisors lifted its position in Solventum by 205.4% during the fourth quarter. JNBA Financial Advisors now owns 339 shares of the company’s stock valued at $27,000 after purchasing an additional 228 shares in the last quarter. Finally, CYBER HORNET ETFs LLC bought a new stake in Solventum during the second quarter valued at about $28,000.

Solventum Stock Performance

NYSE SOLV opened at $75.29 on Thursday. The company has a quick ratio of 0.75, a current ratio of 1.07 and a debt-to-equity ratio of 0.96. Solventum Corporation has a twelve month low of $62.38 and a twelve month high of $88.20. The business has a 50-day moving average price of $75.87 and a 200-day moving average price of $74.34. The firm has a market cap of $13.04 billion, a price-to-earnings ratio of 9.23, a price-to-earnings-growth ratio of 1.18 and a beta of 0.66.

Solventum (NYSE:SOLV) last issued its earnings results on Tuesday, May 5th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.35 by $0.13. Solventum had a return on equity of 23.51% and a net margin of 17.33%.The company had revenue of $2.01 billion for the quarter, compared to the consensus estimate of $1.97 billion. During the same quarter last year, the company earned $1.34 EPS. The firm’s quarterly revenue was down 3.0% on a year-over-year basis. Solventum has set its FY 2026 guidance at 6.600-6.600 EPS. As a group, equities research analysts predict that Solventum Corporation will post 6.58 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms recently issued reports on SOLV. Stifel Nicolaus reduced their target price on shares of Solventum from $105.00 to $90.00 and set a “buy” rating for the company in a report on Wednesday, May 6th. BMO Capital Markets started coverage on shares of Solventum in a report on Wednesday. They set a “market perform” rating and a $81.00 price target on the stock. Rothschild & Co Redburn started coverage on shares of Solventum in a research report on Tuesday, March 24th. They issued a “sell” rating and a $60.00 price target for the company. Weiss Ratings cut shares of Solventum from a “hold (c+)” rating to a “hold (c)” rating in a research note on Friday, June 26th. Finally, Wedbush started coverage on shares of Solventum in a research report on Friday, May 15th. They set an “outperform” rating and a $94.00 price objective on the stock. Seven equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Solventum has a consensus rating of “Hold” and a consensus price target of $83.50.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.